Not A Scam
|This is an Excellent program, one of those 1 in 1/2 a million that comes along. I was a little hesitant at first but as I was looking it over and playing with the set up it had already started making me money. within 10 hours I had made $245.00. Now as I write this report I am into the begining of the 3rd day and my profit is now $578.00. So it was worth every penny I paid for it. Now I pride myself in being and extreme Power user and programmer so setting this up and getting the money coming in quick probably went a lot faster for me then it would some people. although it is very easy to setup for the layman also. Just don't get discouraged if it takes a day or two more to get the money coming in for you, because beleive me, no matter how little you know, if you follow the instructions the money will come in with this system. If your still skeptical, and you have that right, then remember you have bought it through Clickbank. Clickbank is very Customer orientated and you will have no problem returning something you are not satisfied with. I have returned a fair amount of Software back to Clickbank after doing a review and I have never had a problem. Fill out a return form and simply state it was not as expected or it didn't do as you wanted and you will get a confirmation form and once that is returned your money will be refunded almost immediately, usually within 24 hours. NO QUESTIONS ASKED! And Clickbank gives you up to 8 weeks to return the product. So don't take my word for it. Buy it, try it, and if I am wrong simply return it for a full refund within 8 weeks. Like you I get tired of hearing the BS. the so called Guru's feed us about thier product. But your bound to get 1 out of 30 or 40 products that really does work and everyone misses out on it because of all the crap going around scares everyone off. well this is one of those 1 out of 30 or 40 that really works, so don't miss out, remember you can get a full refund up to 8 weeks later.|
To settle FTC charges, Beiersdorf, Inc., must stop claiming that people who regularly use its Nivea My Silhouette! skin cream can reduce their body size significantly. Beiersdorf marketed the cream in nationwide television ads, including one featuring a woman applying My Silhouette! cream to her stomach and thighs, and then fitting into an old pair of jeans. The company has agreed to pay $900,000 for refunds. Find the skinny on weight loss ads at FatFoe.
Ruling in favor of the FTC, a federal judge has ordered Real Wealth, Inc., and Lance Murkin, its owner, to pay $10.4 million – the amount people spent for the work-at-home and grant schemes the company sold. The defendants' direct mail campaign baited at least 100,000 people into buying products that supposedly would have allowed them to "collect up to $9,250" with a "simple 3 minute form," or "rake in up to $1,500+ per week" by learning "secrets" about the "$700 billion banking industry bailout." But few, if any, of the customers made the promised income with the defendants' products. The court also banned Real Wealth and Murkin from marketing or selling work-at-home or grant-related products and from helping others do so.
Three men who allegedly used their company to deceive more than 13,000 desperate homeowners have been ordered to pay nearly $19 million to provide refunds. According to the FTC, the trio behind First Universal Lending told homeowners that the company would negotiate with lenders to modify their mortgages to make them more affordable. They even encouraged the homeowners to stop making mortgage payments so the lenders would negotiate. But, the agency said, the defendants charged the homeowners up to $7,000 in advance fees and then did little or nothing to help them. The settlement order also bans the defendants from the mortgage relief services business. If you're having trouble making your mortgage payments, see ftc.gov/yourhome.
Teletrack, Inc., a company that sells credit reports to payday lenders, rent-to-own stores, and certain auto lenders, among other businesses, has agreed to pay $1.8 million to settle FTC charges that it violated the Fair Credit Reporting Act (FCRA). The FTC's complaint alleges that Teletrack created a database with information mined from its credit reporting business, and then sold the information to marketers looking to target potential customers. But a sales pitch isn't a "permissible purpose" under FCRA, said the FTC. Credit reports are supposed to help companies make decisions about whether to provide credit to their customers, and on what terms – not to serve as marketing tools.
The FTC has shut down a company for allegedly scamming immigrants. The agency claimed that the couple behind Loma International Business Group, Inc., lied about being authorized by the U.S. government to provide immigration services. This follows an earlier FTC action against Immigration Center, one of several companies allegedly masquerading as a U.S. government website, and tricking people into paying fees the company falsely claimed would cover processing fees charged by U.S. Citizenship and Immigration Services. Navigating U.S. immigration laws can be complex, and missing a deadline or choosing the wrong form can jeopardize a person's immigration status – or make it hard to remain in the U.S. legally. Immigrants with limited English language proficiency often are the target of scammers who call themselves "immigration consultants" or "notarios" or who falsely claim that they're attorneys. That's why the FTC is distributing education materials in English, Spanish, Chinese, and Korean, and rolling out six new radio public service messages in English, Spanish, and Mandarin Chinese about immigration scams.
The FTC has approved a final order settling charges that Hikma Pharmaceuticals PLC's acquisition of certain Baxter Healthcare Corp. assets was anticompetitive. According to the FTC, Hikma Pharmaceuticals' $111.5 million purchase of rival Baxter Healthcare would likely have led to higher prices for two generic injectable drugs used to control seizures and treat allergies, nausea, pain, and anxiety. To settle the charges, Hikma has agreed to sell the two drugs – phenytoin and promethazine – to X-Gen Pharmaceuticals, a firm with 40 products and an active product development pipeline. The FTC agrees that X-Gen can replace the competition that would have been lost due to the merger.